MAX-001 not checked

Maxona Pharmaceuticals, Inc.

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 2 trial completes
Trials
1 active
1 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
Tested for
Impacted Third Molar Tooth, Tooth Extraction Status Nos
Main trialPhase 2
“This is a single center, randomized, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of MAX-001 in participants with post-operative dental pain after wisdom teeth removal.”In the company’s words, NCT07937657 on ClinicalTrials.gov

Coming up1

Changes1

Last 90 days

Trials1

TrialPhaseCompletesWhat it tests
Phase 2Not yet recruiting Jun 2027 A Study to Evaluate the Safety and Pain Relief of MAX-001 After Surgical Removal of Wisdom Teeth
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow MAX-001

Following is part of Solo: you see every change to MAX-001 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in